NDC 50090-6560-01 - Albuterol Sulfate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-6560
- Requested NDC
- 50090-6560-01
- Package NDCs from labels
- 50090-6560-0, 50090-6560-1, 50090-6560-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2023-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Albuterol Sulfate - A-S Medication Solutions | A-S Medication Solutions | 2023-07-24 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-6560-0 | Albuterol Sulfate | 3 mL in 1 POUCH | SOLUTION | 3 | 3 | |
| 50090-6560-0 | Albuterol Sulfate | 25 in 1 CARTON | SOLUTION | 25 | 3 | |
| 50090-6560-1 | Albuterol Sulfate | 75 in 1 CARTON | SOLUTION | 75 | 3 | |
| 50090-6560-1 | Albuterol Sulfate | 3 mL in 1 POUCH | SOLUTION | 3 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-6560 | ALBUTEROL SULFATE SOLUTION [A-S MEDICATION SOLUTIONS] | 3 | Current NDC, 4 package rows | 20230725_8f52f15f-3fb7-4b00-a19f-8721c5ac55db.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-6560-0 | ML - Milliliter | 50090-6560 | 92f92e8c-34ec-4fc0-9ed0-d66fe8473ea2 | 1 | 2023-09-05 |
| 50090-6560-1 | ML - Milliliter | 50090-6560 | f21a7011-d7af-40de-b122-7ca696d2ca09 | 1 | 2023-09-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Albuterol Sulfate Inhalation Solution | ALBUTEROL SULFATE | Ritedose Pharmaceuticals, LLC | d4c532be-1f41-60d3-e053-2995a90a98be | 2026-04-30 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Ritedose Pharmaceuticals, LLC | b72742df-1a6b-4483-aff3-3e79db5e015d | 2026-04-30 | Warnings, Adverse reactions | 630208 021SEF3731 |
| albuterol sulfate | ALBUTEROL SULFATE | Sportpharm LLC | 440a96bb-9e69-bdcc-e063-6294a90a6793 | 2026-04-24 | Warnings, Adverse reactions | 021SEF3731 |
| Sodium Chloride | SODIUM CHLORIDE | Sportpharm LLC | a2c111f6-74d5-4a5d-82ac-d0f237488cb8 | 2026-04-24 | Warnings, Adverse reactions | 451W47IQ8X |
| Albuterol Sulfate | ALBUTEROL SULFATE | Sportpharm LLC | a33e20e0-3936-450d-a9d9-3ff51c6f26c5 | 2026-04-24 | Warnings, Adverse reactions | ANDA074880 630208 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Sportpharm LLC | e31d8d13-ac19-4738-97d4-d7790ce2e8e3 | 2026-04-24 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol sulfate | ALBUTEROL SULFATE | Sportpharm LLC | 32d954ee-9790-4beb-95db-72dbf8efa639 | 2026-04-24 | Warnings, Adverse reactions | 021SEF3731 |
| Sodium Chloride | SODIUM CHLORIDE | Method Pharmaceuticals, LLC | 4b08859e-65bd-8255-e063-6394a90af614 | 2026-04-23 | Warnings | 451W47IQ8X |
| Albuterol Sulfate | ALBUTEROL SULFATE | Cardinal Health 107, LLC | d2132c1c-0f90-4c6f-afc0-f3814b6a7e5c | 2026-04-20 | Warnings, Adverse reactions | 630208 021SEF3731 |
| Ringers | SODIUM CHLORIDE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | ICU Medical, Inc. | a926f913-18fa-4a3e-bfd6-210e1e427960 | 2026-04-20 | Warnings, Adverse reactions | 451W47IQ8X |
| Cardioforce II | ABROTANUM, BOLDO, CIMICIFUGA RACEMOSA, KALI PHOSPHORICUM, TARAXACUM OFFICINALE, CONVALLARIA MAJALIS, MAGNESIA SULPHURICA, OLEANDER, NATRUM MURIATICUM, BELLIS PERENNIS | BioActive Nutritional, Inc. | 733bbb26-7698-4a1b-9dc8-7e3490ffc92b | 2026-04-17 | Warnings | 451W47IQ8X |
| Thyroid HP | BARYTA CARBONICA, CALCAREA CARBONICA, FUCUS VESICULOSUS, IODIUM, NATRUM MURIATICUM, PULSATILLA, SPONGIA TOSTA, THYROIDINUM (SUIS) | BioActive Nutritional, Inc. | 3795820a-cf2a-4094-9a02-70e3757b7510 | 2026-04-17 | Warnings | 451W47IQ8X |
| DIANEAL Low Calcium with Dextrose | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | aa268d3f-7389-4f25-801f-5d4825495f08 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | b251752d-7750-482a-9364-0acf4ad47cc8 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 99c6a1a9-cadf-435b-a332-ccc189afdfa9 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
| albuterol sulfate | ALBUTEROL SULFATE | Golden State Medical Supply, Inc. | a22af54a-c010-ab8b-e053-2a95a90a8862 | 2026-04-15 | Warnings, Adverse reactions | 021SEF3731 |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Azurity Pharmaceuticals, Inc. | 7609ecf7-0ce0-4fbb-9c27-30987f689575 | 2026-04-15 | Warnings, Adverse reactions | 451W47IQ8X |
| TRILYTE | POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE | Aurobindo Pharma Limited | 79f5e596-8d51-4227-afcc-f5e341150957 | 2026-04-15 | Warnings, Adverse reactions | 451W47IQ8X |
| Anxiety Relief | ACONITUM NAPELLUS, ARGENTUM NITRICUM, ARSENICUM ALBUM, AURUM METALLICUM, GELSEMIUM SEMPERVIRENS, HYOSCYAMUS NIGER, IGNATIA AMARA, KALI CARBONICUM, MOSCHUS, NATRUM MURIATICUM, PIPER METHYSTICUM | NaturalCare | 9f982e89-655c-49be-85d8-4099a02ed021 | 2026-04-15 | Warnings | 451W47IQ8X |
| PEG 3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | 4e442a72-b13b-4869-8a1d-59356095b091 | 2026-04-14 | Warnings, Adverse reactions | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.